Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Pattern recognition and endocytic receptors on antigen-presenting cells (APCs) comprise a broad functional class of proteins, including Toll-like receptors (TLRs), C-type lectin receptors (CLRs), and NOD-like receptors (NLRs), that identify pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs) (Kawai & Akira, 2011). These receptors are essential for the innate immune system's ability to sense infection or tissue damage and initiate inflammatory signaling pathways (Janeway & Medzhitov, 2002). Endocytic receptors within this group, such as the mannose receptor (CD206) and DEC-205, are specialized for the uptake of antigens, facilitating their processing and presentation to T cells to trigger adaptive immunity (Figdor et al., 2002). In drug development, specific members of this class are targeted by agonists to act as vaccine adjuvants or by antagonists to treat chronic inflammatory and autoimmune diseases (Kastenmüller et al., 2014). For example, TLR7/8 agonists like imiquimod are used topically for skin malignancies, while TLR4 ligands are incorporated into vaccine formulations to boost immunogenicity. Because this term describes a wide-ranging group of receptors with distinct structures and signaling mechanisms, it is considered a functional category rather than a single specific therapeutic target.
Activation or inhibition of specific innate immune sensing pathways and antigen uptake mechanisms to modulate the immune response.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pattern recognition and endocytic receptors on antigen-presenting cells.